William W. Brooke - 29 Jun 2022 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
Director
Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
MXCT
Transactions as of
29 Jun 2022
Net transactions value
$0
Form type
4
Filing time
08 Jul 2022, 16:04:50 UTC
Previous filing
11 Aug 2021
Next filing
23 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Stock Option (right to buy) Award $0 +26,900 $0.000000 26,900 29 Jun 2022 Common Stock 26,900 $4.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date.